LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 1235 | 1552 | 4929 | 0.3149 | 0.1209 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 1235 | 559 | 4474 | 0.1249 | -0.3478 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 1235 | 638 | 4578 | 0.1393 | -0.2953 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 1235 | 793 | 4929 | 0.1609 | -0.1994 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 1235 | 3726 | 4355 | 0.8554 | 0.8353 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 1235 | 3989 | 4277 | 0.9326 | 0.9236 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 1235 | 3949 | 4583 | 0.8616 | 0.8485 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 1235 | 3632 | 4355 | 0.8338 | 0.8097 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 1235 | 3681 | 4277 | 0.8606 | 0.8392 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 1235 | 3610 | 4583 | 0.7876 | 0.7628 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 1235 | 3133 | 4355 | 0.7193 | 0.6683 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 1235 | 2953 | 4277 | 0.6904 | 0.6263 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 1235 | 3172 | 4583 | 0.6921 | 0.6462 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 1235 | 2662 | 4355 | 0.6111 | 0.5253 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 1235 | 2885 | 4277 | 0.6745 | 0.6052 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 1235 | 2568 | 4583 | 0.5603 | 0.4722 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 1235 | 2269 | 4355 | 0.5209 | 0.3969 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 1235 | 2338 | 4277 | 0.5466 | 0.4275 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 1235 | 2389 | 4583 | 0.5212 | 0.4170 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 1235 | 1652 | 4355 | 0.3793 | 0.1731 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 1235 | 1483 | 4277 | 0.3467 | 0.1071 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 1235 | 1597 | 4583 | 0.3484 | 0.1452 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 1 | F06 | 72 | hr | 1235 | 4148 | 4355 | 0.9523 | 0.9469 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 2 | F06 | 72 | hr | 1235 | 3983 | 4277 | 0.9312 | 0.9220 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 3 | F06 | 72 | hr | 1235 | 4169 | 4583 | 0.9096 | 0.9022 |